Disease-Adaptive ROS-Responsive MOF-818 Nanozyme Microneedles for Localized Catalytic Antioxidant Therapy of Psoriasis

Skin is a remarkable barrier, a resilient shield that keeps the body safe from the outside world. Yet, for millions of people, this barrier becomes a site of relentless conflict. Psoriasis is a chronic condition where the skin's natural renewal cycle goes into overdrive. Instead of shedding dead cells slowly over weeks, the skin produces new cells too quickly, leading to thick, red, scaly patches that itch and burn. Underlying this visible chaos is a hidden storm of chemical stress. The affected skin accumulates high levels of reactive oxygen species, unstable molecules that damage cells and fuel inflammation. This creates a vicious cycle: the inflammation causes more stress, and the stress worsens the inflammation. While doctors have treatments to calm the skin, getting medicine to work deep enough to stop this cycle is difficult. The outer layer of skin is tough, and many drugs simply cannot penetrate it effectively. Furthermore, standard treatments often release medicine at a constant rate, regardless of whether the skin is currently in a severe flare-up or a quiet phase, which can lead to side effects or wasted medication.

Researchers at The Hong Kong University of Science and Technology (Guangzhou) and the University of Hong Kong have developed a new way to tackle this problem. They created a smart patch made of tiny, painless needles that can deliver medicine directly into the skin, but with a twist: the patch only releases its medicine when it senses the specific chemical stress of psoriasis. This approach combines a powerful antioxidant material with a delivery system that acts like a responsive trigger. The goal was to build a treatment that adapts to the disease, delivering a heavy dose of relief exactly when and where the skin needs it most, while leaving healthy skin alone.

The core of this new treatment is a material called MOF-818. Imagine a microscopic sponge made of metal and organic links, structured with tiny holes that allow it to interact with chemicals. This material acts like a natural enzyme found in the body, specifically one that breaks down harmful oxygen molecules. In the lab, the researchers showed that MOF-818 could rapidly neutralize two types of dangerous oxygen compounds that build up in psoriatic skin: superoxide and hydrogen peroxide. Unlike natural enzymes, which can be fragile and expensive to produce, this synthetic material is stable and can work for a long time without losing its power. However, simply having this material is not enough; it needs a way to get through the thick, hardened skin of a psoriasis patient.

To solve the delivery problem, the team built a patch of microneedles. These are not the long, sharp needles used for injections, but rather a grid of hundreds of tiny, solid spikes, each less than a millimeter tall. They are made strong enough to pierce the tough outer layer of the skin but dissolve once they are inside. The researchers loaded these needles with the MOF-818 material and mixed it with a gel made from two other ingredients: a modified form of a natural sugar found in the body and a compound found in green tea leaves. These ingredients were linked together by a special chemical bond that is sensitive to oxygen stress. In normal conditions, these bonds hold the gel together tightly. But when the patch encounters the high levels of oxygen stress found in a psoriasis flare-up, the bonds break apart.

This design creates a system that responds directly to the disease. When the microneedles are pressed onto healthy skin, they stay intact and release very little medicine. But when they touch the inflamed, oxygen-rich skin of a psoriasis patient, the chemical bonds snap. This causes the gel to dissolve quickly, releasing a burst of the MOF-818 antioxidant and the green tea compound right where they are needed. The researchers tested this behavior in the lab by placing the needles in a solution that mimicked the chemical environment of inflamed skin. They observed that the needles dissolved and released their contents much faster in the oxygen-rich solution than in normal water, confirming that the system works as a responsive trigger.

To see if this approach works in a living system, the team tested it on mice that had been induced to develop psoriasis-like symptoms on their ears. The mice were divided into groups, with some receiving the full smart patch and others receiving patches with only parts of the ingredients. The results were clear. The mice treated with the full smart patch showed the most significant improvement. Their ear swelling went down, and the thick, scaly skin became much thinner and closer to normal. In contrast, mice treated with patches that lacked the oxygen-sensitive trigger or the specific antioxidant material did not improve as much. The researchers also measured the size of the mice's spleens, an organ that often enlarges when the body is fighting a widespread inflammatory response. The mice treated with the smart patch had spleen sizes that were closer to normal, indicating that the treatment reduced the overall inflammation in the body.

Looking closely at the skin tissue under a microscope, the researchers found that the treatment stopped the rapid growth of skin cells that causes the thickening. They also saw a reduction in the signals that tell the immune system to attack the skin. The number of immune cells, specifically T cells and macrophages, that had gathered in the skin lesions dropped significantly in the treated mice. This suggests that by removing the chemical stress and delivering the antioxidant directly to the site, the treatment broke the cycle of inflammation and cell overgrowth. The researchers also checked for safety, finding that the materials did not harm red blood cells or cause damage to the internal organs of the mice.

This study demonstrates that it is possible to create a skin treatment that senses the disease and reacts to it. By combining a stable, enzyme-mimicking material with a delivery system that breaks down only under the specific conditions of psoriasis, the researchers have shown a new path for managing this difficult skin condition. The approach offers a way to deliver medicine precisely where it is needed, avoiding the limitations of current creams that struggle to penetrate the skin and the risks of systemic drugs that affect the whole body. While further research is needed to understand the long-term effects and to bring this technology to human patients, the work provides a compelling example of how smart materials can be designed to work in harmony with the body's own chemical signals.